1. Home
  2. KODK vs SION Comparison

KODK vs SION Comparison

Compare KODK & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KODK
  • SION
  • Stock Information
  • Founded
  • KODK 1880
  • SION 2019
  • Country
  • KODK United States
  • SION United States
  • Employees
  • KODK N/A
  • SION N/A
  • Industry
  • KODK Business Services
  • SION
  • Sector
  • KODK Consumer Discretionary
  • SION
  • Exchange
  • KODK Nasdaq
  • SION NYSE
  • Market Cap
  • KODK 512.9M
  • SION 338.0M
  • IPO Year
  • KODK N/A
  • SION 2025
  • Fundamental
  • Price
  • KODK $6.73
  • SION $12.57
  • Analyst Decision
  • KODK
  • SION Strong Buy
  • Analyst Count
  • KODK 0
  • SION 1
  • Target Price
  • KODK N/A
  • SION $32.00
  • AVG Volume (30 Days)
  • KODK 1.2M
  • SION 128.6K
  • Earning Date
  • KODK 05-08-2025
  • SION 05-25-2025
  • Dividend Yield
  • KODK N/A
  • SION N/A
  • EPS Growth
  • KODK 33.41
  • SION N/A
  • EPS
  • KODK 0.90
  • SION N/A
  • Revenue
  • KODK $1,043,000,000.00
  • SION N/A
  • Revenue This Year
  • KODK N/A
  • SION N/A
  • Revenue Next Year
  • KODK N/A
  • SION N/A
  • P/E Ratio
  • KODK $7.07
  • SION N/A
  • Revenue Growth
  • KODK N/A
  • SION N/A
  • 52 Week Low
  • KODK $4.26
  • SION $7.26
  • 52 Week High
  • KODK $8.24
  • SION $25.19
  • Technical
  • Relative Strength Index (RSI)
  • KODK 59.57
  • SION N/A
  • Support Level
  • KODK $6.14
  • SION N/A
  • Resistance Level
  • KODK $6.79
  • SION N/A
  • Average True Range (ATR)
  • KODK 0.24
  • SION 0.00
  • MACD
  • KODK 0.06
  • SION 0.00
  • Stochastic Oscillator
  • KODK 93.01
  • SION 0.00

About KODK Eastman Kodak Company Common New

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

Share on Social Networks: